newsfilter
← Latest News
GlobeNewswire·

Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal

FLORHAM PARK, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ:CELU) (the "Company"), a regenerative medicine company developing and commercializing placental-derived technologies, today announced that